Skip to main content
. 2019 Nov 11;10:1298. doi: 10.3389/fphar.2019.01298

Table 3.

Contribution of HO-1 up-regulation to the biological effects of Ginkgo biloba in preclinical in vitro and in vivo models.

Preclinical model G. biloba (concentration or dose) Effect(s) Reference(s)
Myoblasts 25–100 µg/mL Cytoprotection from alcohol-induced oxidative damage (Wang et al., 2015)
Endothelial cells 50–200 µg/mL Endothelial protection from high-glucose- or TNF-α–induced vascular oxidative damage; cytoprotection against cigarette smoke-induced apoptosis in lungs (Hsu et al., 2009; Chen et al., 2011; Tsai et al., 2013)
Macrophages 1–100 µg/mL Inhibition of inflammatory damage in LPS-treated cells; regulation of cholesterol homeostasis and reduction in atherosclerosis lesion size (Tsai et al., 2010; Ryu et al., 2012)
Ethanol-induced liver damage in rats 48 or 96 mg/kg intragastric for 90 days Reduction of oxidative damage and improvement of ethanol-induced microvesicular steatosis and parenchimatous degeneration in hepatocytes (Yao et al., 2007)

LPS, lipopolysaccharide; TNF, tumor necrosis factor.